BRIEF—Steve Couldwell named Tissue Regenix CEO

Following the sudden resignation of Antony Odell as chief executive of UK-based regenerative medicine company Tissue Regenix last month, Steve Couldwell has been named as his replacement.

Mr Couldwell has been in the position of non- executive director of the company since July 2013 and has more than 25 years of experience working in the pharmaceutical and medical device industry.

Most recently he was chief operating officer of Sanofi Biosurgery, a business unit of the French pharma major.